The easiest million dollars I ever made in the market was beneath the rubble of Martha Stewart and Sam Waksal.

It was late December 2001, and the people in the know had already sold their shares of ImClone due to the FDA's rejection of Erbitux. But it wasn't until the close of business on Dec. 28 when a press release informed us all. The next day, the stock was in a freefall. There was no bottom in sight.